Terry Smith's CPRX Position Overview
Terry Smith (via Fundsmith Llp) currently holds 3.36 M shares of Catalyst Pharmaceuticals, Inc. (CPRX) worth $66.27 M, representing 0.33% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 3 quarters.
Based on 13F filings, Terry Smith has maintained this position in CPRX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 654,721 shares.
Analysis based on 13F filings available since 2013 Q2
Terry Smith's Catalyst Pharmaceuticals (CPRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Catalyst Pharmaceuticals (CPRX) Trades by Terry Smith
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2025 | +2.15 M | New Buy | 2.15 M | $24.25 |
| Q2 2025 | +557,812 | Add 25.93% | 2.71 M | $21.70 |
| Q3 2025 | +654,721 | Add 24.17% | 3.36 M | $19.70 |
Terry Smith's Catalyst Pharmaceuticals Investment FAQs
Terry Smith first purchased Catalyst Pharmaceuticals, Inc. (CPRX) in Q1 2025, acquiring 2,151,274 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Terry Smith has held Catalyst Pharmaceuticals, Inc. (CPRX) for 3 quarters since Q1 2025.
Terry Smith's largest addition to Catalyst Pharmaceuticals, Inc. (CPRX) was in Q1 2025, adding 2,151,274 shares worth $52.17 M.
According to the latest 13F filing for Q3 2025, Terry Smith's firm, Fundsmith Llp, owns 3,363,807 shares of Catalyst Pharmaceuticals, Inc. (CPRX), valued at approximately $66.27 M.
As of the Q3 2025 filing, Catalyst Pharmaceuticals, Inc. (CPRX) represents approximately 0.33% of Terry Smith's publicly disclosed stock portfolio, making it one of their key holdings.
Terry Smith's peak holding in Catalyst Pharmaceuticals, Inc. (CPRX) was 3,363,807 shares, as reported at the end of Q3 2025.